Valeant and Progenics Announce PDUFA Date Extension for Oral RELISTOR

-Agency requests standard three-month extension to review additional solicited information-

-New PDUFA date set for July 19, 2016-

LAVAL, Quebec and TARRYTOWN, N.Y., April 4, 2016 /CNW/ — Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) and Progenics…